TARS logo

Tarsus Pharmaceuticals, Inc. (TARS)

Profile

Full Name

Tarsus Pharmaceuticals, Inc.

Ticker

NASDAQ: TARS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 16, 2020

Indexes

Not included

Website

https://www.tarsusrx.com

Employees

323

Key Details

Price

$49.36(-4.84%)

Market cap

$2.08B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$182.95M(+948.62% YoY)

Annual EPS

-$3.07(+33.55% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $49.36
    TARS price is $49.36

    30-Day Relative Volume

    1.68
    TARS 30-day relative volume is 1.68

    Price Performance

    Price Most recent change

    -4.84%
    TARS price was down -4.84% on Sep 12, 2025

    Price YTD change

    -10.85%
    TARS price is down -10.85% since January 1st

    Price 1-year change

    +48.41%
    TARS price is up +48.41% year-on-year

    Price 3-year change

    +209.08%
    TARS price is up +209.08% over the past 3 years

    Price Range

    Price All-time high

    $63.69
    TARS price is currently -22.50% below its historical high of $63.69

    Price 3-year low

    $11.33
    TARS price is currently +335.66% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.08B
    TARS market capitalization is $2.08 billion

    Market cap 3-year change

    +389.43%
    TARS market capitalization is up +389.43% over the past 3 years

    Market cap All-time high

    $2.48B
    TARS market capitalization is currently -16.13% below its historical high of $2.48 billion

    Market cap sector rank

    81.38%
    TARS market capitalization is higher than 81.38% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +10.97%
    TARS shares outstanding is up +10.97% year-on-year

    Shares Outstanding 3-Year Change

    +58.35%
    TARS shares outstanding is up +58.35% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.61
    TARS beta is 0.61

    200-day SMA

    $48.01
    TARS price is currently +2.81% above its 200-day simple moving average

    50-day SMA

    $48.28
    TARS price is currently +2.25% above its 50-day simple moving average

    RSI

    36.86
    TARS 14-day relative strength index is 36.86

    Volume

    1.68
    TARS 30-day relative volume is 1.68

    ATR

    $2.15
    TARS average true range is $2.15

    10-day Historical Volatility

    32.60%
    TARS 10-day historical volatility is 32.60%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $182.95M
    TARS annual revenue is $182.95 million

    Revenue Analysts estimate

    $425.61M
    TARS annual revenue is currently -57.01% lower than the consensus analysts' forecast

    Revenue 1-year change

    +948.62%
    TARS annual revenue is up +948.62% year-on-year

    Revenue Sector rank

    73.21%
    TARS annual revenue is higher than 73.21% of companies in Healthcare sector

    EPS

    EPS

    -$3.07
    TARS annual earnings per share is -$3.07

    EPS Analysts estimate

    -$1.50
    TARS annual earnings per share is currently +104.67% higher than the consensus analysts' forecast

    EPS 1-year change

    +33.55%
    TARS annual earnings per share is up +33.55% year-on-year

    EPS Sector rank

    28.07%
    TARS annual earnings per share is higher than 28.07% of companies in Healthcare sector

    Profit

    Gross profit

    $170.13M
    TARS annual gross profit is $170.13 million

    Gross margin

    92.99%
    TARS annual gross profit margin is 92.99%

    Operating profit

    -$120.57M
    TARS annual operating income is -$120.57 million

    Operating margin

    -65.90%
    TARS annual operating profit margin is -65.90%

    Net income

    -$115.55M
    TARS annual net profit is -$115.55 million

    Net margin

    -63.16%
    TARS annual net profit margin is -63.16%

    Expenses

    Total expenses

    $303.52M
    TARS annual total expenses is $303.52 million

    Operating expenses

    $290.70M
    TARS annual total operating expenses is $290.70 million

    Cost of goods sold

    $12.83M
    TARS annual cost of goods sold is $12.83 million

    Selling, general & administrative expenses

    $237.31M
    TARS annual SGA is $237.31 million

    Depreciation and amortization

    $1.23M
    TARS annual depreciation & amortization is $1.23 million

    Interest expense

    $0.00
    TARS annual interest expense is $0.00

    Income tax

    $0.00
    TARS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$108.11M
    TARS annual earnings before interest & taxes is -$108.11 million

    EBITDA

    -$106.88M
    TARS annual EBITDA is -$106.88 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $377.35M
    TARS annual total assets is $377.35 million

    Non current assets

    $20.29M
    TARS annual long term assets is $20.29 million

    Current assets

    $356.70M
    TARS annual total current assets is $356.70 million

    Cash and cash equivalents

    $94.82M
    TARS annual cash & cash equivalents is $94.82 million

    Accounts receivable

    $46.76M
    TARS annual accounts receivable is $46.76 million

    Inventory

    $2.62M
    TARS annual inventory is $2.62 million

    Liabilities

    Total liabilities

    $152.81M
    TARS annual total liabilities is $152.81 million

    Long term liabilities

    $71.84M
    TARS annual total long term liabilities is $71.84 million

    Current liabilities

    $80.61M
    TARS annual total current liabilities is $80.61 million

    Accounts payable

    $27.74M
    TARS annual accounts payable is $27.74 million

    Debt

    Total debt

    $72.45M
    TARS annual total debt is $72.45 million

    Total debt 1-year change

    +128.33%
    TARS annual total debt is up +128.33% year-on-year

    Long term debt

    $71.84M
    TARS annual long term debt is $71.84 million

    Short term debt

    $608.00K
    TARS annual short term debt is $608.00 thousand

    Equity & Capital

    Shareholders equity

    $224.53M
    TARS annual stockholders equity is $224.53 million

    Book value

    $224.53M
    TARS annual book value is $224.53 million

    Retained earnings

    -$360.21M
    TARS annual retained earnings is -$360.21 million

    Working capital

    $276.09M
    TARS annual working capital is $276.09 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$83.03M
    TARS annual cash flow from operations is -$83.03 million

    Cash from operations 1-year change

    +29.33%
    TARS annual cash flow from operations is up +29.33% year-on-year

    Cash from investing

    -$199.19M
    TARS annual cash flow from investing activities is -$199.19 million

    Cash from investing 1-year change

    -241.67%
    TARS annual cash flow from investing activities is down -241.67% year-on-year

    Cash from financing

    $154.66M
    TARS annual cash flow from financing activities is $154.66 million

    Cash from financing 1-year change

    +18.81%
    TARS annual cash flow from financing activities is up +18.81% year-on-year

    CAPEX

    CAPEX

    $6.57M
    TARS annual capital expenditures is $6.57 million

    CAPEX 1-year change

    +19.36%
    TARS annual capital expenditures is up +19.36% year-on-year

    Free Cash Flow

    Free cash flow

    -$89.59M
    TARS annual free cash flow is -$89.59 million

    Free cash flow 1-year change

    +27.16%
    TARS annual free cash flow is up +27.16% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    92.99%
    TARS annual gross profit margin is 92.99%

    Operating margin

    -65.90%
    TARS annual operating profit margin is -65.90%

    Net margin

    -63.16%
    TARS annual net profit margin is -63.16%

    ROA & ROE

    ROA

    -35.91%
    TARS annual return on assets is -35.91%

    ROE

    -54.83%
    TARS annual return on equity is -54.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TARS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TARS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    6.26
    TARS price to book ratio is 6.26

    PB ratio Sector rank

    82.83%
    TARS price to book ratio is higher than 82.83% of companies in Healthcare sector

    PS Ratio

    PS ratio

    7.05
    TARS price to sales ratio is 7.05

    PS ratio Sector rank

    65.97%
    TARS price to sales ratio is higher than 65.97% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.77B
    TARS enterprise value is $1.77 billion

    Enterprise value Sector rank

    79.37%
    TARS enterprise value is higher than 79.37% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -21.72
    TARS EV/EBITDA is -21.72

    EV/EBITDA Sector rank

    6.63%
    TARS EV/EBITDA is higher than 6.63% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.43
    TARS annual current ratio is 4.43

    Quick ratio

    4.39
    TARS annual quick ratio is 4.39

    Leverage

    Debt to equity

    0.32
    TARS annual debt to equity ratio is 0.32

    Interest coverage ratio

    -
    TARS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    TARS piotroski f-score is 3

    Altman Z-Score

    7.26
    TARS altman z-score is 7.26

    Analyst ratings

    Recent major analysts updates

    May 5, 25 Goldman Sachs
    Neutral
    May 2, 25 Guggenheim
    Buy
    Mar 6, 25 Jefferies
    Buy
    Feb 26, 25 HC Wainwright & Co.
    Buy
    Feb 26, 25 Guggenheim
    Buy
    Feb 26, 25 Barclays
    Overweight
    Feb 24, 25 Guggenheim
    Buy
    Feb 10, 25 Guggenheim
    Buy
    Jan 27, 25 Barclays
    Overweight
    Jan 22, 25 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with TARS included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Tarsus Pharmaceuticals, Inc.?
    • Does Tarsus Pharmaceuticals, Inc. pay dividends?
    • What sector is Tarsus Pharmaceuticals, Inc. in?
    • What industry is Tarsus Pharmaceuticals, Inc. in?
    • What country is Tarsus Pharmaceuticals, Inc. based in?
    • When did Tarsus Pharmaceuticals, Inc. go public?
    • Is Tarsus Pharmaceuticals, Inc. in the S&P 500?
    • Is Tarsus Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Tarsus Pharmaceuticals, Inc. in the Dow Jones?
    • When was Tarsus Pharmaceuticals, Inc.'s last earnings report?
    • When does Tarsus Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Tarsus Pharmaceuticals, Inc.?

    The ticker symbol for Tarsus Pharmaceuticals, Inc. is NASDAQ:TARS

    Does Tarsus Pharmaceuticals, Inc. pay dividends?

    No, Tarsus Pharmaceuticals, Inc. does not pay dividends

    What sector is Tarsus Pharmaceuticals, Inc. in?

    Tarsus Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Tarsus Pharmaceuticals, Inc. in?

    Tarsus Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Tarsus Pharmaceuticals, Inc. based in?

    Tarsus Pharmaceuticals, Inc. is headquartered in United States

    When did Tarsus Pharmaceuticals, Inc. go public?

    Tarsus Pharmaceuticals, Inc.'s initial public offering (IPO) was on October 16, 2020

    Is Tarsus Pharmaceuticals, Inc. in the S&P 500?

    No, Tarsus Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Tarsus Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Tarsus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Tarsus Pharmaceuticals, Inc. in the Dow Jones?

    No, Tarsus Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Tarsus Pharmaceuticals, Inc.'s last earnings report?

    Tarsus Pharmaceuticals, Inc.'s most recent earnings report was on August 6, 2025

    When does Tarsus Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Tarsus Pharmaceuticals, Inc. is November 10, 2025
    On this page